DENTSPLY SIRONA (NASDAQ:XRAY) will post its quarterly earnings results before the market opens on Thursday, May 6th. Analysts expect DENTSPLY SIRONA to post earnings of $0.55 per share for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.
DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Sunday, February 28th. The medical instruments supplier reported $0.87 earnings per share for the quarter, beating analysts’ consensus estimates of $0.64 by $0.23. The business had revenue of $1.08 billion during the quarter, compared to analyst estimates of $997.38 million. DENTSPLY SIRONA had a negative net margin of 1.40% and a positive return on equity of 7.13%. The company’s quarterly revenue was down 2.6% compared to the same quarter last year. During the same period in the previous year, the business earned $0.73 EPS. On average, analysts expect DENTSPLY SIRONA to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Shares of XRAY opened at $68.95 on Wednesday. The firm has a market cap of $15.04 billion, a PE ratio of -299.78, a P/E/G ratio of 5.06 and a beta of 0.98. The company has a current ratio of 3.10, a quick ratio of 2.38 and a debt-to-equity ratio of 0.47. The firm has a fifty day simple moving average of $64.24 and a two-hundred day simple moving average of $56.12. DENTSPLY SIRONA has a 1-year low of $36.12 and a 1-year high of $69.01.
The business also recently announced a quarterly dividend, which was paid on Friday, April 9th. Shareholders of record on Friday, March 26th were paid a dividend of $0.10 per share. The ex-dividend date of this dividend was Thursday, March 25th. This represents a $0.40 dividend on an annualized basis and a yield of 0.58%. DENTSPLY SIRONA’s dividend payout ratio is presently 16.33%.
A number of brokerages have weighed in on XRAY. Piper Sandler boosted their target price on shares of DENTSPLY SIRONA from $63.00 to $70.00 and gave the company an “overweight” rating in a research note on Monday, March 1st. HC Wainwright reiterated a “neutral” rating and set a $60.00 target price (up from $55.00) on shares of DENTSPLY SIRONA in a research note on Tuesday, March 2nd. Robert W. Baird upped their price objective on DENTSPLY SIRONA from $62.00 to $71.00 and gave the stock an “outperform” rating in a research note on Tuesday, March 2nd. Barclays upped their price objective on DENTSPLY SIRONA from $50.00 to $55.00 and gave the stock an “underweight” rating in a research note on Tuesday, March 2nd. Finally, Barrington Research upgraded DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $71.00 price objective for the company in a research note on Monday, March 8th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $55.08.
In related news, Director Eric Brandt sold 7,600 shares of the company’s stock in a transaction on Wednesday, March 17th. The shares were sold at an average price of $63.21, for a total value of $480,396.00. Following the completion of the transaction, the director now owns 38,131 shares of the company’s stock, valued at approximately $2,410,260.51. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Gregory T. Lucier bought 5,000 shares of the company’s stock in a transaction that occurred on Thursday, March 4th. The stock was purchased at an average cost of $58.95 per share, with a total value of $294,750.00. Following the acquisition, the director now directly owns 13,850 shares in the company, valued at approximately $816,457.50. The disclosure for this purchase can be found here. Corporate insiders own 0.53% of the company’s stock.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Recommended Story: Short Selling – Explanation For Shorting Stocks
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.